CureVac curevac.com


Public list: Unicorns - Billion Dollar Startups (363) BIO 2016 (619) Pharma Startups (6570) Cancer Therapeutics (1180)

CureVac, a German clinical stage biopharmaceutical company, serves the field of mRNA-based technology platforms for medical purposes, in which unmodified mRNA is specifically optimized and formulated. CureVac has been developing mRNA-based cancer immunotherapies and prophylactic vaccines against infectious diseases – both under the brand RNActive. Moreover, CureVac's technology RNArt is designed as molecular therapy to trigger the body's own production of therapeutic proteins without stimulati...Show all

CureVac, a German clinical stage biopharmaceutical company, serves the field of mRNA-based technology platforms for medical purposes, in which unmodified mRNA is specifically optimized and formulated. CureVac has been developing mRNA-based cancer imm...Show all

Company (Alive / Active)

Phone: +49 7071 9 20 53 - 100

Fax: +49 70 71- 9 20 53 - 11

Paul-Ehrlich-Strasse 15

Tubingen, D-72076
Germany

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
CureVac $468.3M Feb 27, 2019

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related CureVac Jobs

jobs by Indeed job
						search

Investors

Investor Investor Type Location Participating Rounds
See all 12 investors
There is no Competitors data available for this company. Please select another tab.